Literature DB >> 15937020

Iron, lipids, and risk of cancer in the Framingham Offspring cohort.

Arch G Mainous1, Brian J Wells, Richelle J Koopman, Charles J Everett, James M Gill.   

Abstract

Iron and lipids combine to create oxidative stress, and oxidative stress has a role in the development of cancer. The objective was to determine the risk of cancer among persons who had both elevated iron and lipids. The authors conducted an analysis of the cohort available in the Framingham Offspring Study. Adults aged 30 or more years at baseline had serum iron and high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol, and very low density lipoprotein cholesterol (VLDL-C) assessed in 1979-1982 and were followed for development of cancer until 1996-1997 (n = 3,278). Cox regression models were computed while controlling for age, gender, smoking status, and body mass index. In adjusted models, both elevated iron (hazard ratio (HR) = 1.66, 95% confidence interval (CI): 1.11, 2.46; 29 cases) and VLDL-C (HR = 1.54, 95% CI: 1.04, 2.28; 93 cases) had significant independent risks for development of cancer. When elevated iron was combined with elevated VLDL-C, the adjusted relative risk of cancer increased (HR = 2.68, 95% CI: 1.49, 4.83; 18 cases). Elevated iron and low HDL-C also had a significant adjusted relative risk of cancer (HR = 2.82, 95% CI: 1.50, 5.28; 14 cases). The results suggest that elevated serum iron levels coupled with either high VLDL-C or low HDL-C appear to interact to increase cancer risk in this cohort.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937020     DOI: 10.1093/aje/kwi131

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

1.  Elevated transferrin saturation, health-related quality of life and telomere length.

Authors:  Arch G Mainous; Robert U Wright; Mary M Hulihan; Waleed O Twal; Christine E McLaren; Vanessa A Diaz; Gordon D McLaren; W Scott Argraves; Althea M Grant
Journal:  Biometals       Date:  2013-12-15       Impact factor: 2.949

2.  Reliability of serum assays of iron status in postmenopausal women.

Authors:  Anne Zeleniuch-Jacquotte; Qi Zhang; Jisen Dai; Roy E Shore; Alan A Arslan; Karen L Koenig; Jerzy Karkoszka; Yelena Afanasyeva; Krystyna Frenkel; Paolo Toniolo; Xi Huang
Journal:  Ann Epidemiol       Date:  2006-10-05       Impact factor: 3.797

Review 3.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

4.  Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.

Authors:  Amber B Moore; Jackilen Shannon; Chu Chen; Johanna W Lampe; Roberta M Ray; Sharon K Lewis; Minggang Lin; Helge Stalsberg; David B Thomas
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

5.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

6.  Low HDL levels and the risk of death, sepsis and malignancy.

Authors:  Renana Shor; Julio Wainstein; David Oz; Mona Boaz; Zipora Matas; Asora Fux; Aaron Halabe
Journal:  Clin Res Cardiol       Date:  2007-12-01       Impact factor: 5.460

7.  Statin Use and Breast Cancer Prognosis in Black and White Women.

Authors:  Amanda Leiter; Nina A Bickell; Derek LeRoith; Anupma Nayak; Sheldon M Feldman; Neil B Friedman; Alison Estabrook; Tari A King; Kezhen Fei; Rebeca Franco; Emily J Gallagher
Journal:  Horm Cancer       Date:  2017-10-19       Impact factor: 3.869

8.  Telomere length and elevated iron: the influence of phenotype and HFE genotype.

Authors:  Arch G Mainous; Robert U Wright; Mary M Hulihan; Waleed O Twal; Christine E McLaren; Vanessa A Diaz; Gordon D McLaren; W Scott Argraves; Althea M Grant
Journal:  Am J Hematol       Date:  2013-05-13       Impact factor: 10.047

9.  Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women.

Authors:  N D Freedman; M H Derakhshan; C C Abnet; A Schatzkin; A R Hollenbeck; K E L McColl
Journal:  Eur J Cancer       Date:  2010-06-03       Impact factor: 9.162

10.  Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients.

Authors:  Saleh A K Saleh; Heba M Adly; Altaf A Abdelkhaliq; Anmar M Nassir
Journal:  Curr Urol       Date:  2020-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.